INSIGHTS ON DRUG DEVELOPMENT
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "Next Generation Conjugates: Process And Analytical Challenges")
Next Generation Conjugates: Process And Analytical ChallengesExplore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
-
![GettyImages-2160715445-female-scientist-computer-lab-coat]( "Automating High-Throughput Screens Using Patient-Derived Organoids")
Automating High-Throughput Screens Using Patient-Derived OrganoidsMany oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
![Streamlining drug development]( "Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development")
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation DevelopmentExplore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
![GettyImages-1389723406 protein]( "Comprehensive Workflow For The Quantification Of Peptides And Proteins")
Comprehensive Workflow For The Quantification Of Peptides And ProteinsBiologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
What Is A Viral Vector?4/16/2024
Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.
-
Development Of Separation Methods for GLP-1 Synthetic Peptides6/27/2025
Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.
-
Highly Sensitive ELISAs In 90 Minutes9/11/2024
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
Quantification Of Exenatide Using Xevo TQD7/29/2025
Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.
-
Key Metrics In Antibody Drug Development6/26/2025
Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-2067042854-DNA-strand-building-3d]( "Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids")
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
![GettyImages-1268717577-doctor-meeting-with-business-professional-computer-office]( "Accelerating FIH Trials To POC With Speed, Safety, And Certainty")
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Analytical And Testing Services")
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
-
![ÄKTA oligosynt™ oligonucleotide synthesizer]( "Meet The Latest Member Of The Oligo Synthesis Family")
Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.
-
![leica-microsystems-s9-i-heo]( "Stereo Microscopes Reducing Inspection And Rework Time")
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
